ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.A new ALBI-FIB4 score effectively predicts post-hepatectomy liver failure (PHLF) and mortality in hepatocellular carcinoma (HCC) patients. This combined score outperforms existing models, aiding risk stratification for liver resection.
Area Of Science
- Hepatobiliary Surgery
- Oncology
- Liver Physiology
Background
- Post-hepatectomy liver failure (PHLF) is a critical complication after liver resection, particularly in hepatocellular carcinoma (HCC) patients with underlying chronic liver disease.
- Accurate prediction of PHLF and postoperative mortality is essential for optimizing surgical decisions and patient management.
Purpose Of The Study
- To evaluate the predictive capability of a combined liver function and fibrosis marker score (ALBI-FIB4) for PHLF in HCC patients undergoing hepatectomy.
- To compare the performance of the ALBI-FIB4 score against established scoring systems like Child-Pugh and MELD.
Main Methods
- A retrospective study included 215 patients who underwent hepatectomy for HCC.
- Multivariable logistic regression identified independent predictors of PHLF, leading to the development of the ALBI-FIB4 score.
- The predictive performance of ALBI-FIB4 for PHLF, severe PHLF, and 90-day mortality was assessed using AUC values and compared with other scores.
Main Results
- PHLF occurred in 16.3% of patients, with severe PHLF in 9.3%. 90-day mortality was 2.8%.
- The ALBI-FIB4 score demonstrated superior predictive accuracy for PHLF (AUC 0.783) and postoperative mortality compared to individual markers and conventional scores.
- A cutoff value for the ALBI-FIB4 score effectively stratified patients into high-risk (39.1% PHLF) and low-risk (6.6% PHLF) groups.
Conclusions
- The preoperative ALBI-FIB4 score is a robust and superior predictor of PHLF and postoperative mortality in HCC patients undergoing liver resection.
- This novel scoring system can aid clinicians in identifying high-risk individuals, facilitating personalized perioperative management strategies.

